[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@PaulMarganski](/creator/twitter/PaulMarganski) "Is anyone speculating on the timing of the licensing deal @Sarepta Therapeutics made with @Arrowheadpharm as it relates to the timing of negative events for its gene therapy #Elevydis $SRPT $ARWR"  [@PaulMarganski](/creator/x/PaulMarganski) on [X](/post/tweet/1947127684875575583) 2025-07-21 02:53:10 UTC X followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@PaulMarganski
"Is anyone speculating on the timing of the licensing deal @Sarepta Therapeutics made with @Arrowheadpharm as it relates to the timing of negative events for its gene therapy #Elevydis $SRPT $ARWR" @PaulMarganski on X 2025-07-21 02:53:10 UTC X followers, XXX engagements
/creator/twitter::1435993616439185416/posts